Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer

NCT07632365 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Locally Advanced Non-Small Cell Lung Cancer
Unresectable Stage III NSCLC

Interventions

DRUG: Induction chemoimmunotherapy
RADIATION: Concurrent chemoradiotherapy (cCRT)
DRUG: consolidation immunotherapy

Sponsor

Shanghai Chest Hospital

Collaborators

[object Object]
[object Object]